Detalhe da pesquisa
1.
The Bone Marrow Niche in B-Cell Acute Lymphoblastic Leukemia: The Role of Microenvironment from Pre-Leukemia to Overt Leukemia.
Int J Mol Sci
; 22(9)2021 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33922612
2.
Pro-inflammatory cytokines favor the emergence of ETV6-RUNX1-positive pre-leukemic cells in a model of mesenchymal niche.
Br J Haematol
; 190(2): 262-273, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32118299
3.
Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome.
Proc Natl Acad Sci U S A
; 114(20): E4030-E4039, 2017 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28461505
4.
Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants.
Blood
; 137(14): 1980-1984, 2021 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33512459
5.
What is the relevance of Ikaros gene deletions as a prognostic marker in pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia?
Haematologica
; 98(8): 1226-31, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23585525
6.
High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic Leukemia.
Biochem Pharmacol
; 217: 115809, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37717691
7.
Definition and Prognostic Value of Ph-like and IKZF1plus Status in Children With Down Syndrome and B-cell Precursor Acute Lymphoblastic Leukemia.
Hemasphere
; 7(6): e892, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37304931
8.
Treatment outcome of CRLF2-rearranged childhood acute lymphoblastic leukaemia: a comparative analysis of the AIEOP-BFM and UK NCRI-CCLG study groups.
Br J Haematol
; 158(6): 772-7, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22816614
9.
PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120.
EBioMedicine
; 83: 104224, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35985167
10.
Fine tuning of surface CRLF2 expression and its associated signaling profile in childhood B-cell precursor acute lymphoblastic leukemia.
Haematologica
; 100(6): e229-32, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25862705
11.
Inhibition of inflammatory signaling in Pax5 mutant cells mitigates B-cell leukemogenesis.
Sci Rep
; 10(1): 19189, 2020 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33154497
12.
Activin A contributes to the definition of a pro-oncogenic bone marrow microenvironment in t(12;21) preleukemia.
Exp Hematol
; 73: 7-12.e4, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30825516
13.
IKZF1 Deletions with COBL Breakpoints Are Not Driven by RAG-Mediated Recombination Events in Acute Lymphoblastic Leukemia.
Transl Oncol
; 12(5): 726-732, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30877974
14.
Impact of IKZF1 deletions on IKZF1 expression and outcome in Philadelphia chromosome negative childhood BCP-ALL. Reply to "incidence and biological significance of IKZF1/Ikaros gene deletions in pediatric Philadelphia chromosome negative and Philadelphia chromosome positive B-cell precursor acute lymphoblastic leukemia".
Haematologica
; 98(12): e164-5, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24323991
15.
SRC/ABL inhibition disrupts CRLF2-driven signaling to induce cell death in B-cell acute lymphoblastic leukemia.
Oncotarget
; 9(33): 22872-22885, 2018 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29796158
16.
The recombinome of IKZF1 deletions in B-cell precursor ALL.
Leukemia
; 37(8): 1727-1731, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37386080
17.
IKZF1plus Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia.
J Clin Oncol
; 36(12): 1240-1249, 2018 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29498923
18.
TEL/ARG induces cytoskeletal abnormalities in 293T cells.
Cancer Lett
; 241(1): 79-86, 2006 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-16310306
19.
CRLF2 over-expression is a poor prognostic marker in children with high risk T-cell acute lymphoblastic leukemia.
Oncotarget
; 7(37): 59260-59272, 2016 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-27449287
20.
Targeting of hyperactivated mTOR signaling in high-risk acute lymphoblastic leukemia in a pre-clinical model.
Oncotarget
; 6(3): 1382-95, 2015 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-25682198